Court Upholds Sydney Dorcil's Four-Year Doping Ban

American tennis player Sydney Dorcil's appeal against her four-year doping ban has been rejected by the Court of Arbitration for Sport. The International Tennis Integrity Agency initially imposed the ban after she tested positive for boldenone. Dorcil's claim of unintentional ingestion was not substantiated, maintaining the ban until 2027.

American tennis player Sydney Dorcil faced a setback on Tuesday as her appeal against a four-year doping ban was rejected by sport's highest court.

The Court of Arbitration for Sport upheld the International Tennis Integrity Agency's ruling to ban Dorcil until January 12, 2027. This followed her positive test for the anabolic steroid boldenone and its metabolites during the ITF World Tennis Tour event in Lima, Peru, in November 2022.

Dorcil, who reached a career-high singles ranking of 1,255 in January 2023, argued that the presence of boldenone in her system was due to a contaminated vitamin B12 injection. However, CAS stated that she failed to provide sufficient proof that her doping violation was unintentional, which could have potentially reduced her ban to two years.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)